# US 2024/0182959 A1 · Reversibly cross-linked hydrogels, and methods of using the same for cluster amplification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0182959 A1
- Document ID: US20240182959A1
- Status: Published application
- Kind: A1
- Application number: 18/515,013
- Filed: 2023-11-20
- Published: 2024-06-06
- Earliest claimed: 2022-11-21
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Hassan Bohra; Johan Basuki; Wei Wei; Brian Mather
- Web page: https://patentgrep.com/patent/US20240182959A1

## CPC

- C12Q 1/6825: Nucleic acid detection involving sensors
- C12Q 1/6855: Ligating adaptors
- B01L 3/508: {Rigid containers without fluid transport within}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q 1/6853: using modified primers or templates
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- B01L 2200/0647: Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0636: Integrated biosensor, microarrays
- B01L 2300/069: Absorbents; Gels to retain a fluid
- B01L 2300/0809: rectangular shaped
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

Some examples herein provide a hydrogel on a substrate. The hydrogel includes a three-dimensional network of polymer chains; first functional groups coupled to the polymer chains; amplification primers coupled to the polymer chains via the first functional groups; and second functional groups coupled to the polymer chains and reversibly cross-linking the polymer chains to one another. Some examples herein provide a method of using a hydrogel. The method includes hybridizing a target polynucleotide to an amplification primer coupled to a hydrogel; cleaving cross-linkages within the hydrogel within which the target polynucleotide is hybridized to the amplification primer; and amplifying the target polynucleotide using additional amplification primers within the hydrogel within which the cross-linkages have been cleaved.

## Claims

### Claim 1

A hydrogel on a substrate, comprising:
a three-dimensional network of polymer chains;
first functional groups coupled to the polymer chains;
amplification primers coupled to the polymer chains via the first functional groups; and
second functional groups coupled to the polymer chains and reversibly cross-linking the polymer chains to one another.

### Claim 2 (depends on 1)

The hydrogel of claim 1, wherein the first and second functional groups are of different types than one another.

### Claim 3 (depends on 1)

The hydrogel of claim 1, wherein the first and second functional groups are of the same type as one another.

### Claim 4 (depends on 1)

The hydrogel of claim 1, wherein the first and second functional groups independently are selected from the group consisting of: azide, amine, thiol, diol, aldehyde, alkyne, strained cyclooctyne, and an inverse electron-demand (IED) Diels-Alder group.

### Claim 5 (depends on 1)

The hydrogel of claim 1, wherein the second functional groups reversibly cross-link the polymer chains via cleavable molecules.

### Claim 6 (depends on 5)

The hydrogel of claim 5, wherein the cleavable molecules are cleavable using a chemical agent, an enzyme, light, or heat.

### Claim 7 (depends on 6)

The hydrogel of claim 6, wherein the chemical agent comprises an acid.

### Claim 8 (depends on 7)

The hydrogel of claim 7, wherein the cleavable molecules comprise an acetal, ketal, imine, hydrazone, or t-butyl ester that is cleavable by the acid.

### Claim 9 (depends on 6)

The hydrogel of claim 6, wherein the chemical agent comprises a reducing agent.

### Claim 10 (depends on 8)

The hydrogel of claim 8, wherein the cleavable molecules comprise a disulfide bond or azidoalkyl ether that is cleavable using the reducing agent, or allyl ether that is cleavable using a palladium complex of the reducing agent.

### Claim 11 (depends on 6)

The hydrogel of claim 6, wherein the enzyme comprises a DNAase, RNAase, protease, or restriction enzyme, and wherein the cleavable molecules comprise an oligonucleotide that is cleavable using the DNAase, RNAase, protease, or restriction enzyme.

### Claim 12 (depends on 6)

The hydrogel of claim 6, wherein the enzyme comprises a protease enzyme or lysosomal enzyme, and wherein the cleavable molecules comprise a peptide that is cleavable using the protease enzyme or lysosomal enzyme.

### Claim 13 (depends on 6)

The hydrogel of claim 6, wherein the cleavable molecules comprise a Diels-Alder conjugation that is cleavable using heat.

### Claim 14 (depends on 6)

The hydrogel of claim 6, wherein the cleavable molecules comprise a coumarin or nitrobenzene group that is cleavable using light.

### Claim 15 (depends on 1)

The hydrogel of claim 1, wherein the second functional groups comprise host molecules that reversibly cross-link the backbone via guest molecules.

### Claim 16 (depends on 15)

The hydrogel of claim 15, wherein the guest molecules are removable via salt, heat, or pH.

### Claim 17 (depends on 15)

The hydrogel of claim 15, wherein the guest molecules are removable via displacement with a binding partner to the guest molecules.

### Claim 18 (depends on 15)

The hydrogel of claim 15, wherein the host molecules comprise crown ethers and the guest molecules comprise ammonium moieties.

### Claim 19 (depends on 15)

The hydrogel of claim 15, wherein the host molecules comprise beta-cyclodextrins and the guest molecules comprise adamantanes, ferrocenes, or bipyridines.

### Claim 20 (depends on 1)

The hydrogel of claim 1, wherein the second functional groups comprise ligand molecules that reversibly cross-link the backbone via multivalent binding proteins.

### Claim 21 (depends on 20)

The hydrogel of claim 20, wherein the multivalent binding proteins are removable using a denaturing agent.

### Claim 22

A method of using a hydrogel, the method comprising:
depositing a hydrogel on a substrate, the hydrogel comprising three-dimensional network of polymer chains and at least first and second types of functional groups coupled to the polymer chains;
coupling amplification primers to the first functional groups of the deposited hydrogel; and
reversibly stabilizing the deposited hydrogel by reversibly cross-linking the second functional groups of the deposited hydrogel to which the amplification primers are coupled.

### Claim 23

A method of using a hydrogel, the method comprising:
depositing a hydrogel on a substrate, the hydrogel comprising a three-dimensional network of polymer chains, amplification primers coupled to the polymer chains, and functional groups coupled to the polymer chains; and
reversibly stabilizing the hydrogel by reversibly cross-linking the functional groups of the deposited hydrogel to which the amplification primers are coupled.

### Claim 24

A method of using a hydrogel, the method comprising:
depositing a hydrogel on a substrate, the hydrogel comprising three-dimensional network of polymer chains and first functional groups coupled to the polymer chains;
coupling amplification primers to a first subset of the first functional groups of the deposited hydrogel;
converting a second subset of the first functional groups to second functional groups; and
reversibly stabilizing the hydrogel by reversibly cross-linking the second functional groups.

### Claim 25

A method of using a hydrogel, the method comprising:
hybridizing a target polynucleotide to an amplification primer coupled to a hydrogel;
cleaving cross-linkages within the hydrogel within which the target polynucleotide is hybridized to the amplification primer; and
amplifying the target polynucleotide using additional amplification primers within the hydrogel within which the cross-linkages have been cleaved.

### Claim 26 (depends on 25)

The method of claim 25, further comprising swelling the hydrogel after the cleaving and before the amplifying.
